Supplementary Table S20 from Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models
Abstract
Cell-cell interaction changes in anti-PD1 + VEGFRi vs Control according to Liana+
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Renal cell carcinoma treatment
Ferroptosis and cancer prognosis
Publication details
- Publication date
- 26 February 2026
- Language
- EN